Early-Follicular-Phase supplementation with rLH affected ART outcome and endometrial receptivity in patients with poor ovarian response: a single-center, prospective, randomized controlled study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100052658

Enrollment

Unknown

Registered

2021-11-03

Start date

2021-12-31

Completion date

Unknown

Last updated

2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

Experimental group:learly stage rLH

Control group:late stage rLH

Eligibility

Sex/Gender

Female

Age

No minimum to 40 Years

Inclusion criteria

Inclusion criteria: 1. Aged <= 44 years; 2. AFC < 5 or AMH < 1.2ng/ml.

Exclusion criteria

Exclusion criteria: 1. Unconventional stimulus programs such as natural cycle, micro-stimulation and PPOS programs; 2. Unconventional fertility cycles such as PGT cycles and egg donation recipient cycles; 3. Patients with low gonadotropin and low gonadotropin; 4. History of allergy to LH preparations; 5. Tumor history or suspicious tumor diagnosis; 6. Unexplained ovarian enlargement; 7. Subjects who have participated in this study or another clinical drug trial at the same time; 8. Subjects with any active substance abuse or history of drug, drug or alcohol abuse in the past 5 years; 9. Subjects who refuse or fail to comply with the protocol.

Design outcomes

Primary

Measure	Time frame
Number of available eggs;Number of available embryos;	—

Countries

China

Contacts

Public ContactZhu Huili

West China Second University Hospital Sichuan University

13551287548@139.com+86 13551287548

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026